Author Correction: Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease.

Autor:	Rey, Martial, Yang, Menglin, Lee, Linda, Zhang, Ye, Sheff, Joey G., Sensen, Christoph W., Mrazek, Hynek, Halada, Petr, Man, Petr, McCarville, Justin L., Verdu, Elena F., Schriemer, David C.
Předmět:	CELIAC disease GLUTEN GLIADINS MIRROR images SMALL intestine TRANSGENIC mice
Zdroj:	Scientific Reports; 1/18/2023, Vol. 13 Issue 1, p1-2, 2p
Abstrakt:	Graph: Figure 6 Nepenthes fluid protease treatment of gliadin prevents gliadin-induced inflammation in the NOD/DQ8 transgenic mouse model of gluten-sensitivity. Intraepithelial lymphocyte (IEL) counts quantitated by immunostaining of proximal small intestine villi tips, in sensitized mice challenged with pepsin-treated gliadin (positive control), vehicle alone (negative control, gliadin-free diet), fluid protease-treated gliadin (1:264 ratio) and recombinant nepenthesin-II treated gliadin (1:100 ratio). [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.